Microbiology

  1. Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus

    1. Olivier Terrier
    2. Sébastien Dilly
    3. Andrés Pizzorno
    4. Julien Henri
    5. Francis Berenbaum
    6. Bruno Lina
    7. Bruno Fève
    8. Frédéric Adnet
    9. Michèle Sabbah
    10. Manuel Rosa-Calatrava
    11. Vincent Maréchal
    12. Anny Slama Schwok

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Distinct Inductions of and Responses to Type I and Type III Interferons Promote Infections in Two SARS-CoV-2 Isolates

    1. Fu Hsin
    2. Tai-Ling Chao
    3. Yun-Rui Chan
    4. Han-Chieh Kao
    5. Wang-Da Liu
    6. Jann-Tay Wang
    7. Yu-Hao Pang
    8. Chih-Hui Lin
    9. Ya-Min Tsai
    10. Jing-Yi Lin
    11. Sui-Yuan Chang
    12. Helene Minyi Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories

    1. P. Simmonds

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Susceptibility of tree shrew to SARS-CoV-2 infection

    1. Yuan Zhao
    2. Junbin Wang
    3. Dexuan Kuang
    4. Jingwen Xu
    5. Mengli Yang
    6. Chunxia Ma
    7. Siwen Zhao
    8. Jingmei Li
    9. Haiting Long
    10. Kaiyun Ding
    11. Jiahong Gao
    12. Jiansheng Liu
    13. Haixuan Wang
    14. Haiyan Li
    15. Yun Yang
    16. Wenhai Yu
    17. Jing Yang
    18. Yinqiu Zheng
    19. Daoju Wu
    20. Shuaiyao Lu
    21. Hongqi Liu
    22. Xiaozhong Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Evaluation of 19 antiviral drugs against SARS-CoV-2 Infection

    1. Shufeng Liu
    2. Christopher Z. Lien
    3. Prabhuanand Selvaraj
    4. Tony T. Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2

    1. Jason Nomburg
    2. Matthew Meyerson
    3. James A. DeCaprio

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Coronavirus, as a source of pandemic pathogens

    1. T. Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The coronavirus proofreading exoribonuclease mediates extensive viral recombination

    1. Jennifer Gribble
    2. Laura J. Stevens
    3. Maria L. Agostini
    4. Jordan Anderson-Daniels
    5. James D. Chappell
    6. Xiaotao Lu
    7. Andrea J. Pruijssers
    8. Andrew L. Routh
    9. Mark R. Denison

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Insight towards the effect of the multibasic cleavage site of SARS-CoV-2 spike protein on cellular proteases

    1. Kamal Shokeen
    2. Shambhavi Pandey
    3. Manisha Shah
    4. Sachin Kumar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19

    1. Puck B. van Kasteren
    2. Bas van der Veer
    3. Sharon van den Brink
    4. Lisa Wijsman
    5. Jørgen de Jonge
    6. Annemarie van den Brandt
    7. Richard Molenkamp
    8. Chantal B.E.M. Reusken
    9. Adam Meijer

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 49 of 233 Next